This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Ana Graf
Global Program Head at Novartis


Dr. Ana Graf is Global Program Head in Novartis Neuroscience Global Drug Development. In that role, she leads the teams responsible for global development of drug candidates for treatment of neurological diseases.

Over 30 years at Novartis, she was involved in all phases of drug development across a range of indications and therapeutic modalities. Her main focus is on early development in neurodegeneration. Dr.Graf is now overseeing development strategies for early neuroscience portfolio, in close collaboration with Novartis Institutes for Biomedical Research and Business Development and Licensing.

Dr. Graf holds M.D. degree from Universities of Zagreb, Croatia and Zurich, Switzerland. She is based in Basel, Switzerland.

Agenda Sessions

  • Novartis in neuroscience – translating strategy into science and partnering


Speakers at this event